Clinical Trials Directory

Trials / Completed

CompletedNCT01243229

Genetic Analysis of Congenital Diaphragmatic Disorders

Status
Completed
Phase
Study type
Observational
Enrollment
305 (actual)
Sponsor
University of Utah · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The purpose of this study is to understand the genetic causes of congenital diaphragmatic disorders (CDD), namely congenital diaphragmatic hernia (CDH), eventration and hiatal hernia. Specifically, the investigators plan to: 1. Ascertain informative families and sporadic cases with congenital diaphragmatic disorders and obtain appropriate phenotypic data and genetic material (peripheral blood and/or diaphragm tissue sample). 2. Localize the gene(s) for CDD to specific chromosomal segments using linkage analysis, and determine the role of somatic mutations in CDD. 3. Isolate and characterize genes involved in the pathogenesis of CDD. 4. Develop molecular markers that will facilitate accurate diagnosis (including prenatal diagnosis) and permit correlation of phenotypic variation with specific mutations. 5. Compare RNA-sequencing from tissue samples of children without CDH to those children with CDH.

Conditions

Timeline

Start date
2010-10-01
Primary completion
2018-02-28
Completion
2021-06-01
First posted
2010-11-18
Last updated
2023-04-03

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01243229. Inclusion in this directory is not an endorsement.